Cargando…
Brief review on repurposed drugs and vaccines for possible treatment of COVID-19
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of the pandemic coronavirus disease 2019 (Covid-19) has claimed more than a million lives. Various in silico, in vitro, and in vivo studies are being conducted to understand the effect of SARS-CoV-2 on the cellular met...
Autores principales: | De, Priyasha, Chakraborty, Ishita, Karna, Bhargavi, Mazumder, Nirmal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905377/ https://www.ncbi.nlm.nih.gov/pubmed/33639193 http://dx.doi.org/10.1016/j.ejphar.2021.173977 |
Ejemplares similares
-
An insight on sources and biodegradation of bioplastics: a review
por: Pooja, Nag, et al.
Publicado: (2023) -
Drug repurposing for the treatment of COVID-19
por: Kato, Yuri, et al.
Publicado: (2022) -
Repurposing drugs for treatment of COVID-19
por: Venkatesan, Priya
Publicado: (2021) -
Fast Identification of Possible Drug Treatment of Coronavirus Disease −19 (COVID-19) Through Computational Drug Repurposing Study
por: Wang, Junmei
Publicado: (2020) -
Repurposing Existing Drugs for the Treatment of COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)